Floatz logo

Thymosin Alpha 1

Small-Cell Lung Cancer (SCLC)

Sun Yat-sen UniversityPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Small-Cell Lung Cancer (SCLC) cohort.

Asset / SponsorPhaseRating
225ac-abd147
Abdera Therapeutics Inc.
Phase 1CC

Same molecule, other indications

Thymosin Alpha 1 is also rated in:

colorectal cancerDormant
B
Indicative ·
60 / 100
View asset →
melanomaDormant
B
Indicative ·
57 / 100
View asset →
Immune Checkpoint InhibitorDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →